[1]
“EVALUATION OF RISK OF MALIGNANCY INDICES 1, 2, AND 3 IN PRE-OPERATIVE ASSESSMENT OF THE OVARIAN MASSES”, Journal of Pharmaceutical Negative Results, pp. 3275–3282, Dec. 2022, Accessed: Jun. 13, 2026. [Online]. Available: https://mail.pnrjournal.com/index.php/home/article/view/4564